drugset / Trial / NCT07636018

A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144

NCT07636018

Phase 1 Completed 12 enrolled Pfizer
NaCrossoverOpen-labelOther

Summary

The purpose of the study is to learn how the study medicine called fluconazole changes how the body processes the other study medicine called PF-07248144. The study will also look at the safety, tolerability, and how the medicine is changed and removed from the body after taking PF-07248144 alone compared to when it is taken with fluconazole. Fluconazole can change how your body processes some medications so it may change the body's processing of PF-07248144. Multiple blood samples will be collected up to 10 days after each dose of PF-07248144 to determine how much PF-07248144 is in the blood at different times. This will help characterize the pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it) of PF-07248144 alone and when taken with fluconazole.

Timeline

Start
2025-08-26
Primary completion
2025-10-08
Completion
2025-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule Oral
Subject prifetrastat Small molecule Oral

Indications

No indication recorded.